Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
EDITORIAL
Full Access
full
Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!
- Pages: 1255-1256
- First Published: 30 November 2021
COMMENTARY
Full Access
full
The unresolved question on COVID-19 virus origin: The three cards game?
- Pages: 1257-1260
- First Published: 12 December 2021
Full Access
full
Omicron: Call for updated vaccines
- Pages: 1261-1263
- First Published: 20 December 2021
LETTERS TO THE EDITOR
Full Access
full
Antioxidants associated with NSAIDs might even exacerbate the progress of SARS-CoV2 disease
- Pages: 1264-1266
- First Published: 15 November 2021
Full Access
full
Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions
- Pages: 1267-1268
- First Published: 04 December 2021
Full Access
full
Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection
- Pages: 1269-1271
- First Published: 12 December 2021
Full Access
full
Mucormycosis in COVID-19 recovered patients
- Pages: 1272-1273
- First Published: 14 December 2021
Full Access
full
Outcome of COVID-19 in patients with chronic myeloid leukemia: A single centre UK experience
- Pages: 1274-1276
- First Published: 15 December 2021
Full Access
full
The electrostatic potential of the Omicron variant spike is higher than in Delta and Delta-plus variants: A hint to higher transmissibility?
- Pages: 1277-1280
- First Published: 16 December 2021
Full Access
full
On the severity of COVID-19 infections in 2021 in Italy
- Pages: 1281-1283
- First Published: 16 December 2021
Open Access
oa
SARS-CoV-2 omicron variant: Could it be another threat?
- Pages: 1284-1288
- First Published: 19 December 2021
Full Access
full
Follow-up CT of “reversed halo sign” in SARS-CoV-2 delta VOC pneumonia: A report of two cases
- Pages: 1289-1291
- First Published: 21 December 2021
Full Access
full
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
- Pages: 1292-1293
- First Published: 20 December 2021
REVIEWS
Full Access
full
COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts
- Pages: 1294-1299
- First Published: 19 November 2021
Full Access
full
Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19
- Pages: 1300-1314
- First Published: 23 November 2021
Full Access
full
Intestinal viral infections of nSARS-CoV2 in the Indian community: Risk of virus spread in India
- Pages: 1315-1329
- First Published: 26 November 2021
Full Access
full
Host factors and vaccine efficacy: Implications for COVID-19 vaccines
- Pages: 1330-1335
- First Published: 29 November 2021
Full Access
full
COVID-19 vaccinations: The unknowns, challenges, and hopes
- Pages: 1336-1349
- First Published: 29 November 2021
Full Access
full
Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis
- Pages: 1350-1356
- First Published: 30 November 2021
Full Access
full
Advances in laboratory detection methods and technology application of SARS-CoV-2
- Pages: 1357-1365
- First Published: 02 December 2021
Full Access
full
The variants of SARS-CoV-2 and the challenges of vaccines
- Pages: 1366-1372
- First Published: 09 December 2021
Full Access
full
Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges
- Pages: 1373-1390
- First Published: 12 December 2021
Full Access
full
A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation
- Pages: 1391-1401
- First Published: 20 December 2021
RESEARCH ARTICLES
Full Access
full
Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis
- Pages: 1402-1411
- First Published: 12 November 2021
Full Access
full
Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication
- Pages: 1412-1418
- First Published: 12 November 2021
Open Access
oa
Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service
- Pages: 1419-1427
- First Published: 15 November 2021
Full Access
full
Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis
- Pages: 1428-1441
- First Published: 15 November 2021
Full Access
full
Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers
- Pages: 1442-1449
- First Published: 15 November 2021
Full Access
full
Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic
- Pages: 1450-1456
- First Published: 16 November 2021
Full Access
full
Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: A comparative study from southwestern Iran
- Pages: 1457-1464
- First Published: 20 November 2021
Full Access
full
A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021
- Pages: 1465-1472
- First Published: 23 November 2021
Full Access
full
Effectiveness and safety of Ivermectin in COVID-19 patients: A prospective study at a safety-net hospital
- Pages: 1473-1480
- First Published: 23 November 2021
Full Access
full
Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains
- Pages: 1481-1487
- First Published: 23 November 2021
Full Access
full
Study of the effects of interferon β−1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study
- Pages: 1488-1493
- First Published: 25 November 2021
Full Access
full
Establishing reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research
- Pages: 1494-1501
- First Published: 25 November 2021
Full Access
full
Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses
- Pages: 1502-1512
- First Published: 25 November 2021
Full Access
full
Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019
- Pages: 1513-1522
- First Published: 27 November 2021
Full Access
full
Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis
- Pages: 1523-1534
- First Published: 30 November 2021
Full Access
full
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients
- Pages: 1535-1539
- First Published: 01 December 2021
Full Access
full
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients
- Pages: 1540-1549
- First Published: 29 November 2021
Full Access
full
Comparing reliability of ICD-10-based COVID-19 comorbidity data to manual chart review, a retrospective cross-sectional study
- Pages: 1550-1557
- First Published: 30 November 2021
Full Access
full
Total antioxidant capacity as a marker of severity of COVID-19 infection: Possible prognostic and therapeutic clinical application
- Pages: 1558-1565
- First Published: 04 December 2021
Full Access
full
Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine
- Pages: 1566-1580
- First Published: 04 December 2021
Full Access
full
Spatiotemporal evolution, pattern of diffusion, and influencing factors of the COVID-19 epidemic in Hainan Province, China
- Pages: 1581-1591
- First Published: 04 December 2021
Full Access
full
Modeling and forecasting the total number of cases and deaths due to pandemic
- Pages: 1592-1605
- First Published: 08 December 2021
Full Access
full
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multitarget approach
- Pages: 1606-1616
- First Published: 07 December 2021
Full Access
full
Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: A network meta-analysis of randomized controlled trials
- Pages: 1617-1626
- First Published: 09 December 2021
Full Access
full
Omicron variant genome evolution and phylogenetics
- Pages: 1627-1632
- First Published: 10 December 2021
Open Access
oa
Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips
- Pages: 1633-1640
- First Published: 13 December 2021
Full Access
full
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein
- Pages: 1641-1649
- First Published: 15 December 2021
Full Access
full
Antibody responses to COVID-19 vaccines in older adults
- Pages: 1650-1654
- First Published: 17 December 2021
Full Access
full
Influence of the COVID-19 pandemic on the incidence and exacerbation of childhood allergic diseases
- Pages: 1655-1669
- First Published: 21 December 2021
Full Access
full
Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford−AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach
- Pages: 1670-1688
- First Published: 23 December 2021
SHORT COMMUNICATION
Full Access
full
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight
- Pages: 1689-1692
- First Published: 12 November 2021
Full Access
full
Usefulness of SARS-CoV-2 antigen test sample as input for SARS-CoV-2 RT-PCR analysis
- Pages: 1693-1695
- First Published: 16 November 2021
Full Access
full
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
- Pages: 1696-1700
- First Published: 16 November 2021
Full Access
full
Severe neonatal COVID-19: Challenges in management and therapeutic approach
- Pages: 1701-1706
- First Published: 23 November 2021
Full Access
full
Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo
- Pages: 1707-1710
- First Published: 26 November 2021
Full Access
full
SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey
- Pages: 1711-1716
- First Published: 29 November 2021
Open Access
oa
Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea
- Pages: 1717-1722
- First Published: 04 December 2021
Full Access
full
What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life
- Pages: 1723-1727
- First Published: 06 December 2021
Full Access
full
Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa
- Pages: 1728-1733
- First Published: 12 December 2021
Open Access
oa
Sequential dynamics of virological and serological changes in the serum of SARS-CoV-2 infected patients
- Pages: 1734-1737
- First Published: 12 December 2021
Full Access
full
Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective
- Pages: 1738-1744
- First Published: 14 December 2021
Open Access
oa
A rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19
- Pages: 1745-1747
- First Published: 15 December 2021